Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice. | EBioMedicine | 2024 | 38118400 | PubTator, text mining | PubMed |
| Advances in new targets for immunotherapy of small cell lung cancer. | Thorac Cancer | 2024 | 38093497 | PubTator, text mining | PubMed |
| The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment. | Biosci Rep | 2024 | 38051200 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing indicates cordycepin remodels the tumor immune microenvironment to enhance TIGIT blockade's anti-tumor effect in colon cancer. | Int Immunopharmacol | 2024 | 37992442 | PubTator, text mining | PubMed |
| Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen. | J Immunol | 2024 | 37991420 | PubTator, text mining | PubMed |
| Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma. | J Natl Cancer Inst | 2024 | 37944044 | PubTator, text mining | PubMed |
| Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer. | Transl Oncol | 2024 | 37897832 | PubTator, text mining | PubMed |
| Cord blood DNA methylation of immune and lipid metabolism genes is associated with maternal triglycerides and child adiposity. | Obesity (Silver Spring) | 2024 | 37869908 | PubTator, text mining | PubMed |
| NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia. | J Leukoc Biol | 2024 | 37738462 | PubTator, text mining | PubMed |
| Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. | Haematologica | 2024 | 37731380 | PubTator, text mining | PubMed |
| The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities. | Genes Dis | 2024 | 37692512 | PubTator, text mining | PubMed |
| Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma. | Genes Dis | 2024 | 37692499 | PubTator, text mining | PubMed |
| SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia. | Haematologica | 2024 | 37608777 | PubTator, text mining | PubMed |
| NK cell-based tumor immunotherapy. | Bioact Mater | 2024 | 37601277 | PubTator, text mining | PubMed |
| Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs. | Rheumatology (Oxford) | 2024 | 37310903 | PubTator, text mining | PubMed |
| Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics. | Front Immunol | 2023 | 38299154 | PubTator, text mining | PubMed |
| Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity. | Front Immunol | 2023 | 38283365 | PubTator, text mining | PubMed |
| Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation. | Front Immunol | 2023 | 38283344 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. | Front Pharmacol | 2023 | 38264532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=16